Clinical trials
Breast Neoplasms trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 12 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 9 |
| 2020 | 9 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 10 |
| 2024 | 10 |
| 2025 | 10 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 75 |
| Active, not recruiting | 37 |
| Recruiting | 20 |
| Terminated | 14 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 23 |
| AstraZeneca | 14 |
| Novartis Pharmaceuticals | 11 |
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Sanofi | 6 |
| Fundacao Champalimaud | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Pfizer | 4 |
| SOLTI Breast Cancer Research Group | 4 |
| Eli Lilly and Company | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 155 |
| Neoplasm Metastasis | 16 |
| Neoplasms | 14 |
| Triple Negative Breast Neoplasms | 8 |
| Breast Diseases | 4 |
| Neoplasms by Site | 4 |
| Ovarian Neoplasms | 4 |
| Brain Neoplasms | 3 |
| Bone Neoplasms | 2 |
| Breast Neoplasms, Male | 2 |
Trials
Showing 51 to 75 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.